Human Gene TherapyVol. 25, No. 2 Pioneer PerspectiveHerpes Simplex Viral Vectors: Late Bloomers with Big PotentialJoseph C. GloriosoJoseph C. GloriosoSearch for more papers by this authorPublished Online:6 Feb 2014https://doi.org/10.1089/hum.2014.2501AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byViral vector-mediated gene therapy for opioid use disordersExperimental Neurology, Vol. 341Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cellsMolecular Therapy - Methods & Clinical Development, Vol. 21Vectors in gene therapy: Benefit for glioblastoma patientsViral Vectors for Gene Therapy28 June 2020Oncolytic Viruses and Their Potential as a Therapeutic Opportunity in Osteosarcoma8 August 2020Current Trends in Viral Gene Therapy for Human Orthopaedic Regenerative Medicine21 February 2019 | Tissue Engineering and Regenerative Medicine, Vol. 16, No. 4Gene Therapy: Use of Viruses as VectorsSustained FXN expression in dorsal root ganglia from a nonreplicative genomic HSV-1 vector19 November 2017 | The Journal of Gene Medicine, Vol. 19, No. 11Herpesviruses and Their Host Cells: A Successful LiaisonTrends in Microbiology, Vol. 25, No. 3Viral Vector Gene Delivery to the Brain for Treating Neurogenetic Diseases6 June 2017Supramolecular Gene Transfection AgentsEmerging Considerations in Virus-Based Gene Transfer Systems25 October 2016Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN DeficiencyMolecular Therapy, Vol. 24, No. 5Virotherapy: cancer gene therapy at last?30 August 2016 | F1000Research, Vol. 5DNA vaccination for prostate cancer: key concepts and considerations2 July 2015 | Cancer Nanotechnology, Vol. 6, No. 1Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in childrenMolecular Therapy - Oncolytics, Vol. 2 Volume 25Issue 2Feb 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Joseph C. Glorioso.Herpes Simplex Viral Vectors: Late Bloomers with Big Potential.Human Gene Therapy.Feb 2014.83-91.http://doi.org/10.1089/hum.2014.2501Published in Volume: 25 Issue 2: February 6, 2014PDF download